Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated P...
Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature
About this item
Full title
Author / Creator
Li, Cheukfai , Ren, Chongyang , Wen, Lingzhu , Chen, Xiaoqing , Chen, Bo , Zhang, Guochun , Wang, Yulei , Li, Kai , Cao, Li , Jia, Minghan , Mok, Hsiaopei , Lai, Jianguo , Xiao, Weikai , Li, Xuerui and Liao, Ning
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Breast cancer is highly heterogenous with temporal and spatial heterogeneity making it necessary for rebiopsy. DS-8201a, a new potential therapy for human epidermal growth factor receptor 2 (HER2) low expression breast cancer, had been proved that it could overcome heterogenous HER2 expression in a preclinical setting. In January 2014, a 23-year-ol...
Alternative Titles
Full title
Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a84dd838bbab44f9938c51b15348a889
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a84dd838bbab44f9938c51b15348a889
Other Identifiers
ISSN
1179-5549
E-ISSN
1179-5549
DOI
10.1177/11795549211072880
